Boston Trust Walden Corp Has $55.18 Million Stock Position in CorVel Corp. $CRVL

Boston Trust Walden Corp cut its holdings in CorVel Corp. (NASDAQ:CRVL) by 20.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 536,874 shares of the business services provider’s stock after selling 140,956 shares during the period. Boston Trust Walden Corp owned about 1.04% of CorVel worth $55,180,000 at the end of the most recent quarter.

Other large investors have also added to or reduced their stakes in the company. Meeder Asset Management Inc. acquired a new stake in CorVel in the 1st quarter valued at $25,000. von Borstel & Associates Inc. bought a new position in shares of CorVel in the 1st quarter valued at about $28,000. Blue Trust Inc. increased its position in shares of CorVel by 235.4% in the second quarter. Blue Trust Inc. now owns 550 shares of the business services provider’s stock valued at $57,000 after acquiring an additional 386 shares during the last quarter. Allworth Financial LP raised its holdings in CorVel by 4,000.0% during the first quarter. Allworth Financial LP now owns 574 shares of the business services provider’s stock worth $64,000 after acquiring an additional 560 shares in the last quarter. Finally, GAMMA Investing LLC boosted its position in CorVel by 58.6% during the first quarter. GAMMA Investing LLC now owns 685 shares of the business services provider’s stock valued at $77,000 after purchasing an additional 253 shares during the last quarter. Institutional investors and hedge funds own 51.36% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on the company. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of CorVel in a research report on Saturday, September 27th. Wall Street Zen raised shares of CorVel from a “hold” rating to a “buy” rating in a research note on Sunday. One analyst has rated the stock with a Hold rating, Based on data from MarketBeat, the stock currently has a consensus rating of “Hold”.

CorVel Trading Down 1.7%

CRVL stock opened at $71.41 on Tuesday. CorVel Corp. has a 1-year low of $71.20 and a 1-year high of $128.61. The business’s 50 day simple moving average is $83.65 and its 200 day simple moving average is $98.30. The firm has a market capitalization of $3.66 billion, a PE ratio of 36.81 and a beta of 0.95.

CorVel (NASDAQ:CRVL) last announced its quarterly earnings results on Tuesday, August 5th. The business services provider reported $0.52 earnings per share (EPS) for the quarter. CorVel had a return on equity of 32.31% and a net margin of 10.98%.The business had revenue of $234.71 million during the quarter.

Insider Transactions at CorVel

In other news, insider Maxim Shishin sold 12,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $89.16, for a total transaction of $1,069,920.00. Following the completion of the sale, the insider owned 7,050 shares in the company, valued at $628,578. The trade was a 62.99% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Brandon O’brien sold 1,764 shares of the firm’s stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $91.54, for a total transaction of $161,476.56. Following the transaction, the chief financial officer directly owned 8,948 shares in the company, valued at approximately $819,099.92. This represents a 16.47% decrease in their ownership of the stock. The disclosure for this sale can be found here. 44.56% of the stock is currently owned by corporate insiders.

CorVel Profile

CorVel Corporation provides workers’ compensation, auto, liability, and health solutions. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs. The company also offers network solutions services, including automated medical fee auditing, preferred provider management and reimbursement, retrospective utilization review, facility claim review, professional review, pharmacy, directed care, clearinghouse, independent medical examination, and inpatient medical bill review services, as well as Medicare solutions.